‘A completely different ballgame’: female A-level students’ experiences of academic demands, stress and coping by Stubbs, JE, Dorjee, D, Nash, P, Foulkes, L

Students’ perceptions of studying A-levels: factors facilitating and frustrating positive learning experiences by Stubbs, J, Dorjee, D, Nash, P, Foulkes, L

Valuing older people: time for a global campaign to combat ageism by Officer, A, Schneiders, ML, Wu, D, Nash, P, Thiyagarajan, JA, Beard, JR

Ageism, Healthy Life Expectancy and Population Ageing: How Are They Related? by Officer, A, Thiyagarajan, JA, Schneiders, ML, Nash, P, de la Fuente-Núñez, V

Effect of filgotinib on pain in patients with rheumatoid arthritis: results from phase 3 clinical trials by Pope, J, Taylor, P, Kavanaugh, A, Nash, P, Bartok, B, Hasegawa, K, Rao, S, Strengholt, S, Westhovens, R

An approach to determine enthalpies of formation for ternary compounds by Du Y., Wang J., Ouyang Y.F., Zhang L.J., Yuan Z.H., Liu S.H., Nash P.

Get full text

Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-... by Coates, LC, Mease, P, Kronbergs, A, Helt, C, Sandoval, D, Park, SY, Combe, B, Nash, P, Deodhar, A

Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-... by Coates, L, Mease, P, Kronbergs, A, Helt, C, Sandoval, D, Park, SY, Combe, B, Nash, P, Deodhar, A

STRONTIUM RANELATE PREVENTS RADIOLOGICAL PROGRESSION IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS: A RESPONDERS ANALYSIS by Cooper, C, Berenbaum, F, Nash, P, Zamani, O, Cohen-Solal, M, Bianchi, G, Jaime, B, Navarro, F, Reginster, J

Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease by Helliwell, P, Coates, L, Fitzgerald, O, Nash, P, Soriano, E, Husni, M, Hsu, M, Kanik, K, Hendrikx, T, Wu, J, Kudlacz, E

Efficacy of tofacitinib for the treatment of psoriatic arthritis: pooled analysis of two phase 3 studies by Nash, P, Coates, L, Fleischmann, R, Papp, K, Gomez-Reino, J, Kanik, K, Wang, C, Wu, J, Menon, S, Hendrikx, T, Ports, W

Prevention Of Radiological Progression In Patients With Primary Knee Osteoarthritis With Strontium Ranelate by Reginster, J, Chapurlat, R, Berenbaum, F, Nash, P, Zamani, O, Cohen-Solal, M, Bianchi, G, Branco, J, Navarro, F, Cooper, C

Impact of intrapatient variability (IPV) in tacrolimus trough levels on long-term renal transplant function: multicentre collaborative retrospective cohort study protocol. by Goldsmith, PM, Bottomley, MJ, Okechukwu, O, Ross, VC, Ghita, R, Wandless, D, Falconer, SJ, Papachristos, S, Nash, P, Androshchuk, V, Clancy, M

Tofacitinib improves composite endpoint measures of disease in patients with psoriatic arthritis by Helliwell, P, Coates, L, Fitzgerald, O, Nash, P, Soriano, E, Husni, M, Hsu, M, Kanik, K, Hendrikx, T, Wu, J, Kudlacz, E

Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 stu... by Coates, L, Nash, P, Kvien, TK, Gossec, L, Mease, PJ, Rasouliyan, L, Pricop, L, Jugl, SM, Gandhi, KK, Gaillez, C, Smolen, JS

Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study by Coates, LC, Gossec, L, Zimmermann, M, Shawi, M, Rampakakis, E, Shiff, NJ, Kollmeier, AP, Xu, XL, Nash, P, Mease, PJ, Helliwell, PS

Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis by Pournara, E, Kormaksson, M, Nash, P, Ritchlin, CT, Kirkham, BW, Ligozio, G, Pricop, L, Ogdie, A, Coates, LC, Schett, G, McInnes, IB

Safety and efficacy of Tofacitinib, an oral Janus Kinase inhibitor, up to 36 Months in patients with active Psoriatic Arthritis: data from the third interim analysis of OPAL balanc... by Nash, P, Coates, L, Kivitz, A, Mease, P, Gladman, D, Covarrubias-Cobos, J, Fleishaker, D, Wang, C, Kudlacz, E, Menon, S, Fallon, L, Hendrikx, T, Kanik, K

Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, up to 36 months in patients with active psoriatic arthritis: data from the third interim analysis of opal balanc... by Nash, P, Coates, L, Kivitz, A, Mease, P, Gladman, D, Covarrubias-Cobos, J, Fleishaker, D, Wang, C, Kudlacz, E, Menon, S, Fallon, L, Hendrikx, T, Kanik, K

Remission in psoriatic arthritis—where are we now? by Coates, L, Conaghan, P, D'Agostino, M, De Wit, M, Fitzgerald, O, Kvien, T, Lories, R, Mease, P, Nash, P, Schett, G, Soriano, E, Emery, P